Join Now!      Login

Whole Person Wellness Program
 
healthy.net Wellness Model
 
 
FREE NEWSLETTER
 
Health Centers
Key Services
 
Medicial Mistakes?
How many people each year suffer some type of preventable harm that contributes to their death after a hospital visit?
from 46,000 to 78,000
from 78,000 to 132,000
from 132,000 to 210,000
from 210,000 to 440,000

 
 

 A Role for Food Intolerance in Childhood Migraine  
 
The following is one in an ongoing series of columns entitled Dr. Galland's Integrated Medicine by . View all columns in series

avoided during the treatment period. Three weeks after the third injection, foods shown to provoke symptoms during the open trial were again reintroduced. The outcome was assessed by a single criterion: the ability of each child to resume a full normal diet without recurrence of migraine. The results of this experiment, which involved forty children, are shown in Table 3. Eighty per cent of children receiving active treatment, but only twenty-five per cent of those receiving placebo, were able to resume a normal diet without recurrence of headache (p=0.001).

The adjuvant role of beta-glucuronidase in enhancing hyposensitization was discovered by McEwen in 196755. Uncontrolled case reports of the usefulness of EPD for hyposensitization of adolescents and adults with immediate hypersensitivity responses to specific foods were first published in 197556. Double blind placebo-controlled trials have demonstrated the effectiveness of EPD in decreasing the symptoms of seasonal allergic rhinitis provoked by grass pollen56 and in hyposensitization of children with food-induced hyperkinetic syndrome54. The mechanism by which EPD reverses food intolerance is not known. Its effectiveness in the treatment of hayfever57 implies an immunologic effect. Nonetheless, unlike conventional pollen desensitization, which elicits production of blocking antibodies58, EPD treatment of patients with allergic rhinitis does not induce blocking antibody (MS Starr, personal communication). Antigen-induced

leukocyte migration inhibition demonstrates in vitro a cell-mediated immune response which is present in IgE-mediated hayfever59. The leukocytes of cow's milk-sensitive patients with atopic eczema are also inhibited by cow's milk in this test. Brostoff showed that after successful EPD for milk allergy this inhibition disappeared (J. Brostoff, personal communication). This finding suggests that EPD hyposensitizes by reducing cellular responsiveness to allergens. The effectiveness of EPD in the treatment of childhood migraine gives weight to the hypothesis that the basis of migraine for most children is a non-atopic immunologic response to foods or other antigens.

A parallel to the combined immunologic/metabolic hypersensitivity of migraineurs can be found in atopic asthma. It is now widely accepted that atopic asthma has multiple mechanisms of pathogenesis. Contact with specific allergen (e.g. house dust mite) triggers immunologic hypersensitivity60,61, but hyper-responsiveness of the airway to pharmacologic mediators (e.g. histamine62) is also extremely important. Prolonged allergen avoidance not only decreases the frequency of allergen triggered asthmatic attacks but also decreases non-specific bronchial reactivity to histamine challenge63. Asthma is thus an excellent model of the immunologic priming of pharmacologic responsiveness. We believe that lessons learned from asthma research are relevant to migraine and that, for migraine, altered intestinal permeability may be a link between humoral/metabolic and immunologic reactivity.

  

REFERENCES

I Russell A, Levin B, Oberholzer VG. Hyperammonemia : A new instance of an inborn enzymatic defect of the biosynthesis of urea. Lancet 1962; 2: 699

2 Russell A- The implications ofhypemmmonemia in rare and common disorders, including migraine. Mt Sinai J Med XL 1973; 5: 609630; 6: 723

3 Russell A, Oberholzer VG, Levin B. Proc)(I Int Congr Pediat, Tokyo 1965

4 NralquistB. Migraine in children. Int Arch Allergy 1955; 7: 348-355

5 Bille B. Migraine in schoolchildren. Acta Pediatr (suppl) 1962; 51: 136-151

6 Silanpaa M. Changes in the prevalence of migraine and other headache during the first seven school years. Headache 1983; 23:15-19

7 Liveing E. On Megrim, Sick Headaches and Some Allied Disorders. J & A Churchill, London. 1873

8 Pagniez P, Vallery-Raddt P, Nast A. Therapeutique preventative des certaines migraines Presse Med (Paris). 1991; 27: 172

9 Brown RC. The protein of foodstuffs as a factor in the cause of headache. Wisconsin Med J 1920; 19: 337

10 Minot GR. The role of a low carbohydrate diet in the treatment of migraine and headache. Med Clin N Am 1923; 7: 715

11 Rowe A. H. Food Allergy Its Manifestations, Diagnosis and Treatment. Lea and Febiger, Philadelphia, 1931

12 Sheldon J.M., Randolph T.G. Allergy in migraine-like headaches. Am J Med Sci 1935; 190:232-237

13 Unger A.H., Unger L., Migraine is an allergic disease. J Allergy 1952; 23: 429-440

14 Medina J.L., Diamond S. Migraine and atopy. Headache 1976; 15: 271-273

15 Pinnas J.L., Vanselow N.A. Relationship of allergy to headache. Res Clin Stud Headache 1976; 4: 85-93

16 MerTett J., Peatfield R.C., Rose F.C. et al. Food-related antibodies in headache patients. J Neurol Neurosurg Psychiat 1983; 46: 736-742

17 Pradalier A, Weinman S, Larmay J.L. et al. Total IgE, specific IgE and prick tests against food in common migraine - a prospective study. Cephalalgia 1983; 3: 231-234

18 Hannington E. Preliminan- report on tyramine headache. Br Med J 1967; 2: 550-551

19 Hannington E. Monoamine oxidase and migraine. Lancet 1974; 2: 1148-1149

20 Sandler M, Youdin MBH, Hannington E. A phenylethylamine oxidising defect in migraine. Nature 1974; 250: 335-337

21 Glover V, Sandler M, Grant E et al. Transitory decrease in platelet monoamine oxidase activity during migraine attacks. Lancet 1977; 1, 391-393

22 Litflewood J, Glover V, Sandler M. Platelet phenolsulfotranferase deficiency in dietary migraine. Lancet 1982; 2: 983-986

23 Glover V, Littlewood J, Sandler M. et al. Biochemical predisposition to dietary migraine: the role of phenolsulphotransferase. Headache 1983; 23: 53-58

24 Littlewood J.T., Glover V, Davies PTG et al. Red wine as a cause of migraine. Lancet 1988; 1: 558-559

25 Unge G, Malmgren R, Olsson P et al. Effects of dietary-protein restriction upon 5-HT uptake by platelets and clinical symptoms in migraine-like headache. Cephalalgia 1983; 3: 213-218

26 Pryse-Phillips W. Dietary precipitation of vascular headaches. In: Chandra (ed) Food Allergy. Nutrition Research Education Foundation, St John’s Newfoundland, 1987. pp 237-252

27 Wantke F, Goetz M, Jarisch R. Die histaminfircie diaet. Hautarzt 1993; 44: 512-516

28 Forsyth WI, Redmond A. Two controlled trials of tyramine in children with migraine. Dev Med Child Neurol 1974; 16: 794-799

29 Moffatt A. M., Swash M, Scott D. F. Effect of tyramine in migraine; a double-blind study. J Neurol Neurosurg Psychiatr 1972; 35: 496-499

30 Marteletti P. T cells expressing IL-2 receptor in migraine. Acta Neurol (Napoli) 1991; 13: 448-456

31 Marteletti P, Sutherland J, Anastasi E et al. Evidence for immunemediated mechanism in food-induced migraine from a study of activated T-cells, IgG4 subclass, anti-IgG antibodies and circulating immune complexes. Headache 1989; 29: 664-670

32 Marteletti P, Stirparo G, Rinaldi C et al. Disruption of the immunopeptidergic network in dietary migraine. Headache 1993; 33: 524-527

33 Marteletti P, Bussone G, Centoze V et al. Prophylaxis of food-induced migraine with cromolyn sodium: efficacy of short- and long-term use. Cephalalgia 1989 (suppl 10): 441-442

34 Mansfield L.E., Vaughan T.R., Waller S.F. et al. Food allergy and adult migraine: double blind and mediator conformation of an allergic etiology. Ann Allergy 1985; 55: 126-129

35 Monro J,BrostoffJ,Carini C. et al. Food allergy in migraine. Lancet 1980; 2: 1-4

36 Monro J, Carini C, Brostoff J. Migraine is a food allergic disease. Lancet 1984; 2: 719-721

37 Paganelli R, Levinsky R.J., Brostoff J. et al. Immune complexes containing food proteins in normal and atopic subjects after oral challenge and effect of sodium cromoglycate on antigen absorption. Lancet 1979; 1: 1270-1272

38 Doering P. Drug therapy of food allergies. In: Perkins J. E. (ed) Food Allergies and Adverse Food Reactions. Aspen Publishers, Gaithersburg, Maryland. 1990. pp 69-79

39 Egger J. Psychoneurological aspects of food allergy. Europ J Clin Nutr 1991; 45 (suppl 1): 35-45

40 Dupont C. Barau E., Molkhou P. et al. Food-induced alterations of intestinal permeability in children with cow’s milk-sensitive enteropathy and atopic dermatitis. J Pediatr Gastroenterol Nutr 1989; 8: 459-465

41 Barau E., Dupont C. Allergy to cow’s milk proteins in mother's milk or in hydrolized cow's milk infant formulas as assessed by intestinal permeability measurements. Allergy 1994; 49: 395-398

42 Andre C. Andre F, Colin L. Effect of allergen ingestion challenge with and without cromoglycate cover on intestinal permeability in atopic dermatitis, urticaria and other symptoms of food allergy. Allergy (Denmark) 1989; 44 (suppI 9): 47-51

43 Andre C, Andre F, Colin L, Cavagna S. Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium crornoglycate. Ann Allergy (US) 1987; 59: 127-130

44 McEwen L.M., Costantinopolous P. The use of dietary and antibacterial regime in the management of intrinsic allergy. Ann Allergy 1970; 28: 256-266

45 Egger J, Soothill J.F., Carter C.M. et al. Is migraine food allergy? A double-blind placebo-controlled trial of oligoantigenic diet treatment. Lancet 1983; 2: 865-869

46 Egger J. Soothill J..F., Carter C.M. et al. Controlled trial of oligo antigenic treatment in the hyperkineti. syndrome. Lancet 1985; 1: 540-545

47 Carter C.M., Urbanowicz M, Mantilla L. et al. Effects of a few food diet in attention deficit disorder. Arch Dis Childh 1993; 69: 564-568

48 Egger J. Carter C.M., Soothill J.F., Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr 1989; 114: 51-58

49 Galli V, Ciecarone V, Venuta A, Ferrari P. Hemicrania and food in the child. Pediatr Med Chir 1985; 7: 17-21

50 Lucarelli S. Lendvai D, Frediam T et al. Emicrania e allergia alinientare nel bambino. Minerva Pediatr 1990; 42: 215-218

51 Mylek D. Migrena. Jako jeden z objawow alergii pokarmowej. Polski Tygodmk Lekorski 1992; 47: 89-91

52 Guariso G, Bertoli S, Cemetti R et al. Emicrania e intolleranza alimentare: studio controllato in eta evolutiva. Pediatr Med Chir 1993; 15: 57-61

53 McEwen L.M.. Hyposensitization. In: Bristoff J, Challacoimbe S.J. (eds) Food Allergy and Intolerance. Balliere Tindall, London. 1987. pp 985-994

54 Egger J, Stolla, A, McEwen L.M. Controlled trial of hyposensitization in children with food-induced hyperkinetic syndrome. Lancet 1992; 339: 1150-1153

55 McEwen L.M., Starr M.S. Enzyme-potentiated hyposensitization. I. The effects of pre-treatment with B-glucuronidase, hyaluronidase, and antigens on anaphylactic sensitivity of guinea-pigs, rats and mice. Int Arch Allergy l972;42:152-158

   CONTINUED      Previous   1  2  3  4  Next   
 Comments Add your comment 

 About The Author
Leo Galland, M.D. has received international recognition as a leader in the field of Nutritional Medicine for the past 20 years. A board-certified internist, Dr. Galland is a Fellow of the......moreLeo Galland MD, FACN
 
 From Our Friends
 
 
 
Popular & Related Products
 
Popular & Featured Events
2019 National Wellness Conference
     October 1-3, 2019
     Kissimmee, FL USA
 
Additional Calendar Links
 
Dimensions of Wellness
Wellness, Communicating, dimension!

Home       Wellness       Health A-Z       Alternative Therapies       Wellness Inventory       Wellness Center
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Nutrition Center       Fitness Center
Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us
Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
Are you ready to embark on a personal wellness journey with our whole person approach?
Learn More/Subscribe
Are you looking to create or enhance a culture of wellness in your organization?
Learn More
Do you want to become a wellness coach?
Learn More
Free Webinar